Literature DB >> 11749861

Antinociceptive effect of astragalosides and its mechanism of action.

Q Yang1, J T Lu, A W Zhou, B Wang, G W He, M Z Chen.   

Abstract

AIM: To study the effect and mechanism of astragalosides (AST) related to the antinociceptive activity.
METHODS: The standardized formalin test was performed to induce the direct stimulation of nociceptors followed by inflammatory process in the Kunming strain mice. The involvement of opioid and nitric oxide was studied by subcutaneous injection of morphine with/without naloxone 30 min before formalin test, or peritoneal injection of L-arginine with/without L-NAME 20 min before formalin.
RESULTS: AST 20, 40, and 80 mg/kg significantly lowered pain score of the second phase of formalin response as compared with control group (P<0.01). The maximum analgesic effect of AST 40 mg/kg was found at 4 h after the administration of AST (34.4 % inhibition at the second phase). Injection of morphine 5 mg/kg significantly inhibited pain response of both phases (P<0.01) and this was reversed by naloxone 2 mg/kg (P<0.01). However, naloxone did not alter the effect of AST on the second phase. Antinociceptive effect of AST 40 mg/kg was partially blocked by L-arginine 400 or 800 mg/kg (P<0.01).
CONCLUSION: AST has an antinociceptive effect on formalin test in mice that is not mediated by the endogenous opioid system but related to its inhibitory effect on the production of NO.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749861

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  Absorption enhancement study of astragaloside IV based on its transport mechanism in caco-2 cells.

Authors:  C R Huang; G J Wang; X L Wu; H Li; H T Xie; H Lv; J G Sun
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jan-Mar       Impact factor: 2.441

2.  Protective effect of fufanghuangqiduogan against acute liver injury in mice.

Authors:  Shuang-Ying Gui; Wei Wei; Hua Wang; Li Wu; Wu-Yi Sun; Cheng-Yi Wu
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

3.  Astragaloside IV inhibits oxidative stress-induced mitochondrial permeability transition pore opening by inactivating GSK-3β via nitric oxide in H9c2 cardiac cells.

Authors:  Yonggui He; Jinkun Xi; Huan Zheng; Yidong Zhang; Yuanzhe Jin; Zhelong Xu
Journal:  Oxid Med Cell Longev       Date:  2012-09-25       Impact factor: 6.543

4.  Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB.

Authors:  Lei Qiu; Guojian Yin; Li Cheng; Yuting Fan; Wenqin Xiao; Ge Yu; Miao Xing; Rongrong Jia; Ruiqing Sun; Xiuying Ma; Guoyong Hu; Xingpeng Wang; Maochun Tang; Yan Zhao
Journal:  Int J Mol Med       Date:  2015-01-16       Impact factor: 4.101

5.  Effect of astragalosides on long non-coding RNA expression profiles in rats with adjuvant-induced arthritis.

Authors:  Hui Jiang; Fu-Rong Wu; Jian Liu; Xiu-Juan Qin; Nan-Nan Jiang; Wei-Ping Li
Journal:  Int J Mol Med       Date:  2019-07-22       Impact factor: 4.101

6.  Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism.

Authors:  Huan Zhang; Jiaying Song; Huizhen Dai; Yanchao Liu; Lili Wang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

7.  Neuroprotection Effect of Astragaloside IV from 2-DG-Induced Endoplasmic Reticulum Stress.

Authors:  Yu Fu; Jianhang Cai; Mengyao Xi; Yifei He; Yang Zhao; Yi Zheng; Yidong Zhang; Jinkun Xi; Yonggui He
Journal:  Oxid Med Cell Longev       Date:  2020-12-31       Impact factor: 6.543

8.  Apoptosis induced by acrylamide is suppressed in a 21.5% fat diet through caspase-3-independent pathway in mice testis.

Authors:  Xichun Zhang; Fahe Chen; Zhiyong Huang
Journal:  Toxicol Mech Methods       Date:  2009-03       Impact factor: 2.987

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.